Simvastatin for patients with Acute Respiratory Distress Syndrome: long term outcomes and cost-effectiveness from a randomised controlled trial

Agus, A, Hulme, C orcid.org/0000-0003-2077-0419, Verghis, RM et al. (5 more authors) (2017) Simvastatin for patients with Acute Respiratory Distress Syndrome: long term outcomes and cost-effectiveness from a randomised controlled trial. Critical Care, 21. 108. ISSN 1364-8535

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s) 2017. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Keywords: Acute respiratory distress syndrome; statins; critical care; cost-effectiveness; QALYs
Dates:
  • Published: December 2017
  • Accepted: 5 April 2017
  • Published (online): 17 May 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Health Sciences (Leeds) > Academic Unit of Health Economics (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 25 Apr 2017 12:01
Last Modified: 05 Oct 2017 16:26
Status: Published
Publisher: BioMed Central
Identification Number: https://doi.org/10.1186/s13054-017-1695-0

Share / Export

Statistics